Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Fabian Schmidt
Affiliation
The Rockefeller University
ORCID
Career Start Year
2002
Papers
67
H Index
29
Expertise
CM4AI Collaborator
Andrej Sali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36847375
Gene Editing of Primary Rhesus Macaque B Cells.
J Vis Exp
2023
37625266
Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIV.
EBioMedicine
2023
38096415
Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodies.
Proc Natl Acad Sci U S A
2023
37425700
SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity.
bioRxiv
2023
36653360
Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape.
Nat Commun
2023
36473496
Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination.
Nature
2023
35194607
Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose.
bioRxiv
2022
35776090
Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans.
J Exp Med
2022
35636436
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis.
Lancet Microbe
2022
35818364
Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection.
Open Forum Infect Dis
2022
35447092
Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins.
Immunity
2022
35447027
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost.
Nature
2022
36149398
Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans.
J Exp Med
2022
35982682
Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination.
medRxiv
2022
35915556
Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection.
Gut Microbes
2022
35132412
Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins.
bioRxiv
2022
35030645
Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
N Engl J Med
2022
33173867
Evolution of Antibody Immunity to SARS-CoV-2.
bioRxiv
2021
33851164
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.
bioRxiv
2021
33567448
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
Nature
2021
33758864
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies.
bioRxiv
2021
33758856
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies.
bioRxiv
2021
33501451
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
bioRxiv
2021
34936878
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
Cell Rep
2021
34874007
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape.
Elife
2021
34931199
Plasma neutralization properties of the SARS-CoV-2 Omicron variant.
medRxiv
2021
34648371
Replication and single-cycle delivery of SARS-CoV-2 replicons.
Science
2021
34544114
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape.
Nature
2021
34454536
Development of a Web GIS for small-scale detection and analysis of COVID-19 (SARS-CoV-2) cases based on volunteered geographic information for the city of Cologne, Germany, in July/August 2020.
Int J Health Geogr
2021
34716452
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.
Nat Immunol
2021
34534459
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
Cell Rep
2021
34619745
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination.
Nature
2021
34126625
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.
Nature
2021
34100013
Naturally enhanced neutralizing breadth to SARS-CoV-2 after one year.
bioRxiv
2021
34098567
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants.
Nature
2021
34268524
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity.
medRxiv
2021
34234131
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.
Nat Commun
2021
33948592
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
bioRxiv
2021
34331873
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.
Immunity
2021
33461210
Evolution of antibody immunity to SARS-CoV-2.
Nature
2021
33211088
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.
J Exp Med
2021
32511384
Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals.
bioRxiv
2020
33112236
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
Elife
2020
32692348
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.
J Exp Med
2020
32917729
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
J Clin Microbiol
2020
32577675
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients.
medRxiv
2020
32577658
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.
bioRxiv
2020
32577645
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies.
bioRxiv
2020
32743579
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
bioRxiv
2020
32995782
Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection <i>in vivo</i>.
bioRxiv
2020
1 - 50 of 67
Column Actions
Search
Recommended Authors
Sebastian Weigang
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Career Start Year
2018
Number of shared co-authors
2
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
2017
Number of shared co-authors
3
Mir M Khalid
Gladstone Institutes
Career Start Year
2016
Number of shared co-authors
2
Carolina Lucas
Yale School of Medicine
Career Start Year
2014
Number of shared co-authors
0
Laura A VanBlargan
Washington University School of Medicine
Career Start Year
2013
Number of shared co-authors
3
Natalia A Kuzmina
University of Texas Medical Branch, USA Galveston National Laboratory
Career Start Year
2012
Number of shared co-authors
3
Hongjie Xia
University of Texas Medical Branch
Career Start Year
2012
Number of shared co-authors
0
Wilfredo F Garcia-Beltran
Ragon Institute of MGH
Career Start Year
2012
Number of shared co-authors
1
Meagan E Deming
University of Maryland School of Medicine
Career Start Year
2011
Number of shared co-authors
1
Xuping Xie
University of Texas Medical Branch
Career Start Year
2010
Number of shared co-authors
1
Kenneth S Plante
University of Texas Medical Branch
Career Start Year
2009
Number of shared co-authors
4
Vineet D Menachery
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
4
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year
2008
Number of shared co-authors
1
Melissa M Coughlin
Centers for Disease Control and Prevention
Career Start Year
2006
Number of shared co-authors
0
Pavlo Gilchuk
Vanderbilt University Medical Center
Career Start Year
2005
Number of shared co-authors
2
Pavitra Roychoudhury
Fred Hutchinson Cancer Center
Career Start Year
2004
Number of shared co-authors
0
Marek Widera
Goethe University Frankfurt, University Hospital, Institute for Medical Virology
Career Start Year
2004
Number of shared co-authors
0
Natalie J Thornburg
Centers for Disease Control and Prevention (CDC)
Career Start Year
2003
Number of shared co-authors
4
Lingshu Wang
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year
2003
Number of shared co-authors
6
Robert H Carnahan
Vanderbilt University Medical Center
Career Start Year
1997
Number of shared co-authors
2
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year
1997
Number of shared co-authors
8
Pei-Yong Shi
University of Texas Medical Branch
Career Start Year
1996
Number of shared co-authors
3
Cynthia A Derdeyn
University of Washington
Career Start Year
1995
Number of shared co-authors
2
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
3
Ande West
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
3
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Career Start Year
1991
Number of shared co-authors
4
Rafael Delgado
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year
1988
Number of shared co-authors
0
Bart L Haagmans
Erasmus Medical Center
Career Start Year
1986
Number of shared co-authors
1
Michael S Diamond
Washington University School of Medicine
Career Start Year
1982
Number of shared co-authors
8
James E Crowe
Vanderbilt University Medical Center
Career Start Year
1975
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Paul D Bieniasz
The Rockefeller University
Co-authored papers
54
Theodora Hatziioannou
The Rockefeller University
Co-authored papers
52
Yiska Weisblum
Rockefeller University
Co-authored papers
26
Thiago Y Oliveira
The Rockefeller University
Co-authored papers
17
Pamela J Bjorkman
Co-authored papers
15
Hans-Heinrich Hoffmann
The Rockefeller University
Co-authored papers
12
Charles M Rice
Rockefeller University
Co-authored papers
11
Michael P Rout
The Rockefeller University
Co-authored papers
3
Jeffrey D Lifson
Frederick National Laboratory
Co-authored papers
3
David Noah Sather
Center for Global Infectious Disease Research, Seattle Children's Hospital
Co-authored papers
2
John D Aitchison
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Co-authored papers
2
Paul Dominic B Olinares
The Rockefeller University
Co-authored papers
2
Brandon F Keele
Co-authored papers
2
Lucille M Rich
Center for Immunity and Immunotherapies, Seattle Children's Research Institute
Co-authored papers
2
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Co-authored papers
2
David Feny??
Institute for Systems Genetics, NYU Grossman School of Medicine
Co-authored papers
2
Vladimir Vigdorovich
Center for Global Infectious Disease Research, Seattle Children's Hospital
Co-authored papers
2
Sarah R Leist
University of North Carolina at Chapel Hill
Co-authored papers
2
Jason S Debley
Seattle Children's Hospital, University of Washington
Co-authored papers
2
Tanmoy Sanyal
University of California san francisco
Co-authored papers
2
Peter C Fridy
The Rockefeller University
Co-authored papers
2
Kelly R Molloy
The Rockefeller University
Co-authored papers
2
Tongqing Zhou
Co-authored papers
2
Brian T Chait
The Rockefeller University
Co-authored papers
2
Erica Y Jacobs
The Rockefeller University, St John's University
Co-authored papers
2
Robert A Colbert
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Co-authored papers
2
Junjie Wang
The Rockefeller University
Co-authored papers
2
Fred D Mast
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Co-authored papers
2
Natalia E Ketaren
The Rockefeller University
Co-authored papers
2
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers
2
1 - 30